SecBot SecBot

Give Kids a Chance Act of 2024

H.R. 3433 Rep. Michael McCaul (R-TX-10) Passed House
Bill text PDF
  1. Introduced May 17
  2. Committee May 17
  3. Passed House Sep 23
  4. Passed Senate Next
  5. To President Not yet
  6. Law Not yet
Where it stands
Passed House, Sep 23, 2024Next: Senate vote
764d ago Sep 24, 2024: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
6companies, 7 filings
Subscribe to see spend
Member trades
2trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

6 companies
Companies by sector
Biotech & Pharma 6
Search all 6 companies, their asks and price moves Subscribe

Summary

Give Kids a Chance Act of 2023

Full summary3 paragraphs

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.

Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.

The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

Library of Congress summary, May 17, 2023

Summary versions
  • Introduced in HouseMay 17, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.